Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Final Astroworld suit settled
At least 100 killed in landslide
'This means war'
US issues visa restrictions
Support AIDS research
2022 Osprey crash lawsuit
China's 2nd day of war games
Wash. wind farm proposal
First teaser revealed
Arrested, charged w/ fraud
Planet parade 2024
Lovett joins ‘Survivor’ cast
Official images of B21 Raider
Approves ETFs for Ether
Pistons new president?
Planet that could support life
US service members injured
Daytime Emmy Awards hosts
Wins Idaho caucuses
Judge revisits immigration law
Drops ‘Dark Times' album
Ala. coal ash plan rejected
Bong's plane discovered?
OH gov. calls special session
Gets Walk of Fame star
CIA director to visit Europe
AI deals with Hollywood?
Duggan can be extradited
Signs new abortion bill
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax, Sanofi
Novavax shares soar on license deal with Sanofi at lofty valuation
Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with Sanofi for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm at double its current market capitalization.
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to $1.4 billion with Sanofi (SNY, FR:SAN). Novavax sha
Novavax's share price surges after inking co-licensing deal with pharma giant
Gaithersburg's Novavax is getting a big cash infusion after signing a multibillion-dollar deal with French pharmaceutical giant. It's also removing a going-concern warning it issued more than a year ago.
Benefits Pro
11d
Novavax strikes $1.2B deal with Sanofi to develop COVID-flu combo vaccine
With flu and COVID hospital admission rates now mirroring each other,
Novavax
, which lost out in the COVID
vaccine
race ...
4d
on MSN
Shah Capital ends campaign against Novavax board after Sanofi deal
Hedge fund Shah Capital said on Monday it would withdraw its campaign against the re-election of three directors on Novavax's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback